Bioactive NO from Acellular Hbs and Nanoparticles

$411,167P01FY2012HLNIH

Albert Einstein College Of Medicine, Bronx NY

Investigators

Linked publications, trials & patents

Paper 34544605 Paper 32848178 Paper 32075750 Paper 31530172 Paper 31396101 Paper 31085344 Paper 30630954 Paper 30385713 Paper 30327559 Paper 30193183 Paper 29540481 Paper 29311995 Paper 29112633 Paper 29112106 Paper 29070524 Paper 28981425 Paper 28852085 Paper 28770911 Paper 28598831 Paper 28554826 Paper 28328758 Paper 28297647 Paper 28099525 Paper 28069451 Paper 28054978 Paper 28011635 Paper 27881020 Paper 27797281 Paper 27650096 Paper 27626360 Paper 27507623 Paper 27357444 Paper 27355904 Paper 27260322 Paper 27189937 Paper 27120679 Paper 26995402 Paper 26974230 Paper 26924283 Paper 26855790 Paper 26807267 Paper 26798825 Paper 26682653 Paper 26497278 Paper 26496376 Paper 26396189 Paper 26307534 Paper 26240367 Paper 26205820 Paper 26172313 Paper 26017006 Paper 26011432 Paper 25871869 Paper 25750627 Paper 25687963 Paper 25582460 Paper 25538624 Paper 25371199 Paper 25350267 Paper 25302850 Paper 25240595 Paper 25217657 Paper 25060721 Paper 24939847 Paper 24920392 Paper 24703006 Paper 24653740 Paper 24630491 Paper 24597567 Paper 24486321 Paper 24480871 Paper 24418449 Paper 24280809 Paper 24277079 Paper 24177061 Paper 24068932 Paper 24039330 Paper 23978812 Paper 23966236 Paper 23901933 Paper 23820271 Paper 23775069 Paper 23696640 Paper 23606592 Paper 23555800 Paper 23459127 Paper 23330885 Paper 23264625 Paper 23264591 Paper 23249305 Paper 23198874 Paper 23140673 Paper 23116701 Paper 23025383 Paper 22982347 Paper 22938394 Paper 22867830 Paper 22705913 Paper 22702311 Paper 22564169

Abstract

Project 3 Acellular Hb in the circulation has been proposed to be a major source of toxicity and poor outcome for transfusions involving either aged RBCs or HBOCs. One of the major overall objectives of this program project is to test the hypothesis that acellular Hbs contribute to these poor outcomes due to depletion of endothelium-generated NO and that acellular Hb toxicity can be reversed through compensatory mechanisms that generate bioactive NO. Project 3 in conjunction with the other projects will: i) determine the role of bioactive NO in the creation or exacerbation of acellular Hb induced toxicities; and ii) establish of the role of released or nitrite-generated bioactive NO in preventing, limiting, or ameliorating acellular Hb toxicities. Project 3 will contribute to these objectives through the following three

View original record on NIH RePORTER →